Orford Keith 4
4 · Calithera Biosciences, Inc. · Filed Apr 17, 2019
Insider Transaction Report
Form 4
Orford Keith
SR. VP, CLINICAL DEVELOPMENT
Transactions
- Sale
Common Stock
2019-04-15$6.33/sh−416$2,633→ 10,416 total
Footnotes (1)
- [F1]Reported transaction occurred pursuant to a Rule10b5-1 Trading Plan.